Al-`Aqar Healthcare REIT Annual Report 2022

BOARD NOMINATION AND REMUNERATION COMMITTEE REPORT EVALUATION OF THE FUNCTIONING AND PERFORMANCE OF THE BOARD OF DIRECTORS AND ITS COMMITTEES (CONT’D) e) Chairman of the Board of Directors and CEO, where the Directors are asked for their views on the performance of these two positions and fulfilment of responsibilities. f) Other areas, with questions relating to the Board’s response to the industry crisis and improvement opportunities or aspects to be developed in the future. The responses are generally positive and supportive, without prejudice to the Chairman and the CEO, taking into consideration going forward some of the suggestions made regarding the functioning of the Board. From the feedback received from the Directors, a few significant points and recommendations on areas that could be discussed by the Board for potential improvements, which are as follows: • Identification of issues relating to stakeholder management, in terms of identification of the stakeholders and the materiality of their influences on Manager and the Fund. • Achievement of targets relating to gender diversity in the Board’s and Board Committees’. • Enhancement of better communication and engagement channels between the Board and the management team in terms of strategic direction, performance benchmarking, achievement of targets, and accountability on achievement of those targets. • Identification of ESG initiatives and the assimilation of ESG elements in all aspects of the REIT’s business operations. The above issues, if deemed appropriate, to the definition of an action plan for the 5-year strategic planning. For better transparency and in order for the Board to evaluate any potential conflict of interest, each Director reports to the Committee through an annual declaration, the list of listed companies in which they serve as Directors and/or other positions and a Declaration of Interest in Securities (stocks, bonds, note, unit trusts or other securities). The directorships of the Directors in other listed issuers can be found on page 24 of this Annual Report or, https://www.alaqar.com.my/board-of-directors.php. CONCLUSION During the financial year 2022, there have been no circumstances or situations in the areas of responsibility and competence of the Committee that required its intervention and/or report to the Board of Directors. The succession planning of the Board of Directors, senior management team as well as gender diversity are the two areas of relevance on which the Committee will continue to work throughout the financial year 2023, to submit its proposals to the Board of Directors. This annual report was presented to the BNRC dated 16 January 2023 and the Board of Directors on 23 February 2023. AL-`AQAR HEALTHCARE REIT ANNUAL REPORT 2022 116

RkJQdWJsaXNoZXIy NDgzMzc=